Bringing success to antibody biologics development and manufacturing
In an unpredictable drug development environment, small to mid-sized biotechs may want to work with external
partners to increase the chance of bringing success to their drug development projects.
In this article, Jahoon Kang, Vice-President and Head of CDO Development Department, and Yeukyung Yoon, Associate Director in Analytical CMC Development, at Samsung Biologics probe the role of contract development and manufacturing organisations (CDMOs) in providing versatile process development platforms and customised solutions designed to create an optimised set-up for drug manufacturing.
In an unpredictable drug development environment, small to mid-sized biotechs may want to work with external
partners to increase the chance of bringing success to their drug development projects.
In this article, Jahoon Kang, Vice-President and Head of CDO Development Department, and Yeukyung Yoon, Associate Director in Analytical CMC Development, at Samsung Biologics probe the role of contract development and manufacturing organisations (CDMOs) in providing versatile process development platforms and customised solutions designed to create an optimised set-up for drug manufacturing.
- CDO
- CGMP
- ADC
- Bio Campus
- IR
- CMO
Share article